What does Samphire Neuroscience do?

Samphire Neuroscience is a UK-based medtech startup founded in 2021, dedicated to developing neurotechnology for women's chronic health issues. The company focuses on non-hormonal, drug-free solutions, particularly through its flagship product, Nettle, a CE-certified wearable device that uses transcranial direct current stimulation (tDCS) technology. Nettle aims to alleviate menstrual-related pain, mood disorders, and symptoms associated with conditions like PMS, PMDD, endometriosis, and uterine fibroids. Headquartered in London, Samphire Neuroscience has raised $4.65 million in seed funding and is planning to expand into the US market while continuing to grow in the EU. The company emphasizes research-driven innovation tailored to the female brain and offers educational services to help women make informed health decisions. With options for payment plans and rentals, Samphire aims to integrate its solutions seamlessly into women's lives, promoting better care without the side effects of hormonal or pharmaceutical treatments.